Published in MedTech Strategist
Authors: Wendy Diller, Oded Ben-Joseph, Craig Steger, and Thomas Joyce
The COVID-19 crisis shifted unprecedented resources to the diagnostics industry and presented a substantial growth opportunity for test manufacturers. A multitude of companies and entrepreneurs quickly pivoted toward developing innovative COVID tests, but whether they can survive post-pandemic exceptionalism remains to be seen.
BOSTON, MA & RESTON, Va.–(BUSINESS WIRE)–Outcome Capital (www.outcomecapital.com) today announced that Steven Wardell and Karl Hess have joined the firm as Senior Advisors for its rapidly growing life science and healthcare practice, bolstering the firm’s expertise in the digital health segment. As business leaders with extensive hands-on operating and entrepreneurial expertise, Messrs. Hess and Wardell […]Read More
RESTON, Va.–(BUSINESS WIRE)–Outcome Capital, an advisory and investment banking firm that serves middle market growth companies in IT services, software, managed services, ADGS, healthcare and life sciences, is pleased to announce that Evergreen Systems, Inc. (the “Company”) has been acquired by Sunstone Partners, a California-based private equity firm. Outcome Capital provided exclusive advisory services to […]Read More